Literature DB >> 18026738

Patterns of expression of retinoic acid receptor beta 2 (RAR-beta2)-LacZ reporter gene in the embryonic foregut.

Hany O S Gabra1, Sean Marven, Simon J Ward.   

Abstract

Vitamin A and its active form retinoic acid (RA) are essential for normal embryonic development. Maternal vitamin A deficiency in experimental animals is known to produce various developmental anomalies including foregut malformations and lung hypoplasia. However, there is a little known about the role of RA receptors in the developing foregut. Our aim was to study the pattern of expression of retinoic acid receptor beta 2 (RAR-beta2) in the region of the foregut during the early stages of embryonic development. Normal mouse embryos homozygous for the lacZ-fused RAR-beta2 promoter transgene were studied to detect the expression of RAR-beta2 in the embryonic foregut. Transverse and sagittal sections of the embryos were taken at the region of the foregut to observe for The normal pattern of expression of RARbeta2-LacZ between 9.5-12.5 days post conception. RAR-beta2-LacZ was expressed in the foregut tube on 9.5 and 10.5 dpc, mainly in the oesophageal part and maximally in the region of tracheo-oesophageal fold formation. This expression faded on day 11.5, and was not seen on 12.5 dpc. The change of RAR-beta2 expression between 9.5-11.5 dpc coincided with the time of tracheo-esophageal separation of the foregut. Our study has shown a possible RA-driven genetic activity during embryonic foregut development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026738     DOI: 10.1007/s00383-007-2060-1

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  11 in total

1.  An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation.

Authors:  J G WILSON; C B ROTH; J WARKANY
Journal:  Am J Anat       Date:  1953-03

Review 2.  Retinoids and mammalian development.

Authors:  G M Morriss-Kay; S J Ward
Journal:  Int Rev Cytol       Date:  1999

3.  Multiple congenital malformations; a consideration of etiologic factors.

Authors:  J WARKANY; C B ROTH; J G WILSON
Journal:  Pediatrics       Date:  1948-04       Impact factor: 7.124

4.  Dorsoventral patterning in oesophageal atresia with tracheo-oesophageal fistula: Evidence from a new mouse model.

Authors:  Adonis S Ioannides; Bill Chaudhry; Deborah J Henderson; Lewis Spitz; Andrew J Copp
Journal:  J Pediatr Surg       Date:  2002-02       Impact factor: 2.545

5.  Stage-dependent responses of the developing lung to retinoic acid signaling.

Authors:  R Mollard; N B Ghyselinck; O Wendling; P Chambon; M Mark
Journal:  Int J Dev Biol       Date:  2000-08       Impact factor: 2.203

6.  Retinoic acid receptor beta 2 (RAR beta 2) null mutant mice appear normal.

Authors:  C Mendelsohn; M Mark; P Dollé; A Dierich; M P Gaub; A Krust; C Lampron; P Chambon
Journal:  Dev Biol       Date:  1994-11       Impact factor: 3.582

7.  Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos.

Authors:  E Ruberte; P Dolle; P Chambon; G Morriss-Kay
Journal:  Development       Date:  1991-01       Impact factor: 6.868

8.  Retinoic acid receptors and cellular retinoid binding proteins. I. A systematic study of their differential pattern of transcription during mouse organogenesis.

Authors:  P Dollé; E Ruberte; P Leroy; G Morriss-Kay; P Chambon
Journal:  Development       Date:  1990-12       Impact factor: 6.868

9.  Developmental analysis of the retinoic acid-inducible RAR-beta 2 promoter in transgenic animals.

Authors:  C Mendelsohn; E Ruberte; M LeMeur; G Morriss-Kay; P Chambon
Journal:  Development       Date:  1991-11       Impact factor: 6.868

10.  Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing.

Authors:  A Zelent; C Mendelsohn; P Kastner; A Krust; J M Garnier; F Ruffenach; P Leroy; P Chambon
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.